Phase II study of induction chemotherapy with gemcitabine plus 5-fluorouracil followed by gemcitabine-based concurrent chemoradiotherapy for unresectable locally advanced pancreatic cancer

Kurt, Ender; Kurt, MERAL; Kanat, Ozkan; Cetintas, SİBEL; Aygun, Sevilcan; Palazoglu, Julay; Ozkan, Lutfi; Evrensel, TÜRKKAN; Kaya, EKREM; Manavoglu, Osman

doi:10.1177/030089160609200603

Phase II study of induction chemotherapy with gemcitabine plus 5-fluorouracil followed by gemcitabine-based concurrent chemoradiotherapy for unresectable locally advanced pancreatic cancer

Kurt E., Kurt M., Kanat O., Cetintas S., Aygun S., Palazoglu J., ...Daha Fazla

TUMORI, cilt.92, sa.6, ss.481-486, 2006 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 92 Sayı: 6
Basım Tarihi: 2006
Doi Numarası: 10.1177/030089160609200603
Dergi Adı: TUMORI
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.481-486
Bursa Uludağ Üniversitesi Adresli: Evet

Özet

Aims and background: To evaluate the efficacy and tolerability of a new treatment approach including induction chemotherapy (CT) and concurrent chemoradiotherapy (CRT) in unresectable, locally advanced pancreatic cancer (LAPC).